Skip To Main Content
Ali Javaheri on Muck Rack

Ali Javaheri

As seen in: Wiley Online Library, Yahoo Finance, Yahoo Finance Canada, JAMA (The Journal of the American Medical Association), PitchBook, The Journal of Clinical Investigation, JACC (Journal of the American College of Cardiology), International Journal of Electronic Business, Canadian Journal of Cardiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ali

Contact Ali, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Space tech VC funding tops 2025 in just six months Original

|
By Ali Javaheri
| Yahoo Finance Verified
Space startups raised more venture capital in the first half of 2026 than during all of last year, as investors concentrated larger checks in companies moving from technical validation toward manufacturing and production. Venture-backed space companies raised $11.3 billion across 244 deals through June, according to PitchBook's 2026 Vertical Snapshot: Space Tech, surpassing the $10.1 billion invested across 433 deals in all of 2025.
Open in Who Shared View Duplicates (3) Issue with article?

All eyes on the factory in Iran missile crunch

|
By Ali Javaheri
| Yahoo Finance Canada Verified
The Pentagon's scramble to replenish US missile stocks is making weapons production one of the clearest new investment opportunities in defense tech. Manufacturing bottlenecks in motors, explosives and precision components—the inputs needed to build missiles at scale—are holding back production. Yet these constraints are not holding back the flow of capital to the space.
Open in Who Shared View Duplicates (3) Issue with article?

Fluid Management of Acute Heart Failure With the Reprieve System: The Randomized Controlled FASTR Trial

|
By James E. Udelson, Ali Javaheri, Marat Fudim
| JACC (Journal of the American College of Cardiology)
Methods FASTR (Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System [DMS]; NCT05174312) was a randomized, prospective, open-label pilot trial. Its primary goal was optimizing the Reprieve System algorithm and providing proof-of-concept that the Reprieve System can facilitate rapid and safe decongestion compared with a control strategy of optimal diuretic therapy (ODT).
Open in Who Shared Issue with article?
See all 17 articles